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Abstract 
Title Systematic Review: Evaluating the effectiveness of patient-directed educational interventions on 
the uptake of colorectal cancer screening. 
Background Colorectal cancer is the third most common neoplasm in the United States, with over 
150,000 people receiving a new diagnosis every year.1 Colorectal cancer is also the second-leading cause 
of all cancer-associated mortality, attributed to deaths totaling nearly 50,000 annually.1 Despite the 
morbidity and mortality of colorectal cancer and the effectiveness early detection, colorectal cancer 
screening lags behind other types of screening. Patient education and health literacy are posited to play 
a role in the lack of colorectal cancer screening in American adults 
Purpose To evaluate the effectiveness of patient-oriented educational materials, including small media 
and decision aids on the outcomes of screening uptake, patient knowledge, and patient intent.  
Data Sources MEDLINE, CINAHL, hand-searched reference list 
Study Selection One reviewer independently selected studies addressing the study questions and met 
eligibility criteria.  
Data Extraction Information on study design, setting, intervention, comparators, study population, 
outcomes, and quality were extracted by one reviewer. The reviewer assigned a quality rating for each 
study.  
Data Synthesis The reviewer found that with regards to increasing colorectal cancer screening uptake, 
the evidence is mixed, with two studies demonstrating the a positive effect, three demonstrating no 
effect, and one showing a negative effect. All three studies investigating patient knowledge suggest an 
increase in knowledge. Patient intent for screening was mixed, with one study showing a positive effect, 
one showing a negative effect and two showing no effects at all.  
Limitations Only investigated randomized controlled trials as opposed to pre-post test interventions. 
Articles used different measurement tools/methods for assessing outcomes of interest. Limited the 
number of outcomes to only three. Investigated only educational materials while excluding other 
interventions. 
Conclusion Evidence is mixed regarding the effectiveness of patient-directed educational interventions 
on CRC screening uptake. More evidence and standardization of outcomes/methods and educational 
content are needed in order to assess patient intent and uptake of screening. Nevertheless, patient 
educational materials are effective at improving patient knowledge, important especially when informed 
consent and informed decision-making are goals for appropriate care.  
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Introduction 
 Colorectal cancer is the third most common neoplasm in the United States, with over 
150,000 people receiving a new diagnosis every year.1 Colorectal cancer is also the second-
leading cause of all cancer-associated mortality, attributed to deaths totaling nearly 50,000 
annually.1 Studies have demonstrated that colorectal cancer screening is effective at reducing 
mortality and morbidity; the evidence is strong enough to warrant the adoption of screening 
guidelines by the United States Preventive Services Task Force (USPSTF), the American Cancer 
Society (ACS), and the United States Multisociety Task Force on Colorectal Cancer. The USPSTF 
currently recommends that screening should be performed in adults beginning at the age of 50 
years and continuing to 75 years. The clinical recommendations for this population consist of 1) 
annual fecal occult blood testing, 2) flexible sigmoidoscopy every five years, 3) annual fecal 
occult blood testing plus flexible sigmoidoscopy every five years, or 4) colonoscopy every 10 
years.2 
 
Underutilization of Colorectal Cancer Screening in the United States 
 Despite the strength of evidence and the fact that screening interventions have been 
available for decades, many Americans do not undergo routine screening for colorectal cancer. 
Findings from the National Health Interview Survey (NHIS) administered by the Centers for 
Disease Control indicate that only 50% of US adults over the age of 50 years have undergone 
complete screening as described by current guidelines.3 The CDC also states colorectal cancer 
screening lags behind screening for other common neoplasms, such as breast and cervical 
cancer. These numbers relied on self-reporting, however, and are postulated to be 
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overestimates of actual screening rates. A study performed amongst Medicare beneficiaries 
who had adequate coverage and reimbursement for screening also demonstrated underuse of 
screening; only 29.2% of the study cohort had ever been screened and only 25.4% were found 
to be up to date with screening recommendations.4 Although colorectal cancer screening rates 
have increased from less than 25% since the 1980’s, most of this growth is attributed to 
increasing referral for colonoscopy due to Medicare coverage in 2001.4 Other modalities such 
as sigmoidoscopy and fecal occult blood testing decreased in use during the same period.4 
 A number of studies have explored the reasons behind the underutilization of colorectal 
cancer screening the United States.6-8 One factor influencing screening is a recommendation or 
a discussion with a physician concerning colorectal cancer.1 Research also suggests that 
healthcare systems utilizing patient navigators, staff that facilitate follow-up, and electronic 
reminder systems are successful in positively influencing screening for colorectal cancer. 
 The most important patient-related factors determining screening for colorectal cancer 
are insurance status and having a consistent source of primary care.1 Two other positive 
correlates for colorectal cancer screening are income and educational levels.1 A positive 
relationship also exists between colorectal cancer screening and patient knowledge about 
cancer, perceptions of susceptibility and risk to cancer, and strong health promoting behaviors.8 
Although all of these factors exert their own independent effects on a patient’s screening 
status, a number are highly correlated with one another. For example, the higher the 
educational level of a person, the more likely this person is to have a high income level, health 
insurance, and a consistent primary care source. A person with higher education may also 
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understand more concerning the risk s and benefits of colorectal screening as well as the 
reasons behind screening. 
 
Health Literacy and Screening for Colorectal Cancer 
 Health literacy is defined as “the capacity of an individual to obtain, interpret, and 
understand basic health information and services and the competence to use such information 
and services in ways which are health enhancing.”9 Low literacy is common in the United States, 
with more than 90 million American adults scoring in the lowest 2 levels of a 5-level scale aimed 
at evaluating a person’s ability to function in society and achieve one’s goals.10  Studies suggest 
that low health literacy is associated with less knowledge regarding cancer screening, 
diminished screening rates, and worse clinical outcomes.11 Providing written and/or 
inappropriately complex cancer screening information may also be ineffective amongst 
individuals with low health literacy and as a result, patients may be less inclined to pursue 
screening.12 Literacy is also important in the context of patient autonomy in the decision-
making process; patient documents for informed consent may be too complex for a number of 
people, and individuals may undertake suboptimal decision-making in accepting or rejecting 
certain screening interventions.12  
 Health literacy is suggested to impact colorectal cancer screening specifically. 
Unscreened patients are more likely to lack the knowledge regarding the reasons for 
performing colorectal cancer screening.4 Furthermore, patients who have not been screened 
are more likely to not know about screening modalities apart from colonoscopy.4 Limited health 
literacy has also been associated with less knowledge about colorectal cancer and screening11. 
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Patients with more less literacy are also likely to report barriers to the completion of CRC 
screening, even when referred by a physician.11 Three studies have also explored health literacy 
as a predictor of colorectal cancer screening and found no statistically significant association; 
the study sizes of these three studies was small, however, and should not be used to dismiss 
the role of literacy in the underuse of screening.11, 13, 14.  
 
Patient-Oriented Education Materials for Colorectal Cancer Screening 
 Because of the association between lower health literacy and colorectal cancer 
screening, interventions to improve screening rates amongst adults could focus on improving 
patient health literacy and knowledge. Improvement in patient education could allow patients 
to become better engaged in making healthcare decisions, an activity promoted by leading 
healthcare organizations in the United Kingdom, the United States, and Australia.15-17 The 
importance of providing patients with the best available evidence regarding risks, benefits, and 
purposes of screening has led to a demand for tools that would facilitate their involvement in 
healthcare decision-making with providers. A number of patient-level interventions have been 
developed in a variety of healthcare settings, all promoting better informed decision-making 
and improved health education. Such interventions consist of media as varied as computer 
applications, pamphlets and printed items, and patient-directed videos. 
 Recently a number of patient-oriented educational materials have included decision 
aids. Patient decision aids or decision support interventions are designed to assist patients in 
making informed decisions on their health.18  Decision aids differ from other small media 
because they provide patients with information on the options and possible outcomes relevant 
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to their own health through the inclusion of numerical and graphical risk information.19  
Decision aids also contain exercises aimed to help patients arrive at decisions reflecting their 
own beliefs and value systems.19 A systematic review of decision aids for a number of 
healthcare issues suggests that these interventions improve patient knowledge of medical 
options, result in a more appropriate perception of risks, and assist patient clarification with 
regards to the potential outcomes of such options.20 Decision aids are also shown to increase 
the participants of patients in the decision-making process and  further enabled patients to 
better express their desires in discussions with medical professionals.20 
While patient education materials and decision aids are helpful in allowing patients to 
make better informed decisions, they often contain complex information about medical 
concepts and procedures.21 Decision aids also include quantitative information on outcomes 
and risks, all of which require a high level of literacy and numeracy to interpret.21 Some studies 
have shown that even standard forms of patient information are readily misunderstood, with 
two-thirds of cancer patients having difficulties understanding the information they receive and 
over one half searching for information that better suits their needs.22 Given this fact, the 
cognitive burden of these education materials may prove to be a barrier towards their 
effectiveness.  
 
Research Needs for the Evaluation of Patient-Oriented Materials for Colorectal Cancer 
Screening 
Patient-oriented educational items for colorectal cancer are used extensively in clinical 
care. Such items are as varied as pamphlets, videos, and web-based resources, and decision 
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Considerable evidence and research has been performed evaluating decision aids and other 
patient-oriented materials in a variety of other healthcare environments; however, there are no 
meta-analyses or systematic reviews evaluating specific patient education materials for 
colorectal cancer screening. Investigations and research are necessary in order to understand 
the effectiveness of such materials on patient perception of colorectal cancer lifetime risk, the 
harms and benefit of screening, and any effects on patient intent and uptake of screening 
methods. 
 The goal of this systematic review is to evaluate the effectiveness of small media 
interventions and decision aids currently in clinical practice amongst patients aged 50-75 years 
of age who are at average risk for acquiring colorectal cancer. This is of particular importance 
due to the fact that low health literacy may be a barrier to the uptake of colorectal cancer 
screening in American adults. This systematic review aims to investigate the following: 1). Do 
patient education materials  improve patient knowledge regarding colorectal cancer, types of 
screening interventions, and the risks and benefits of screening  interventions when compared 
to usual care?  2). Do small media and decision aids increase the uptake of colorectal cancer 
screening when compared to usual care? 3). Are decision aids and small media educational 
interventions effective at improving a patient’s intent at being screened for colorectal cancer?  
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Methods 
Patient Population, Interventions, Comparators, Settings and Outcomes of Interest (PICOTS) 
 This systematic review seeks to evaluate the effectiveness of decision aids and patient 
education materials at improving screening uptake, patient knowledge and attitudes of 
colorectal cancer screening methods. Specifically, we are interested in whether educational 
materials increase uptake of colorectal cancer screening compared to usual care, improve 
patient knowledge regarding the risks and benefits of screening, and whether such materials 
improve a patient’s intent to pursue screening. The primary population of interest is the 
population for which screening is currently recommended by the USPSTF: adults aged 50-75 
years old. For the purposes of this review, our major goal is to investigate patient education 
materials and decision support techniques/aids amongst those adults at otherwise average risk 
for colorectal cancer. Individuals at greater risk for colorectal cancer due to either a strong 
family history of predisposing conditions (Familial Adenomatous Polyposis, Hereditary 
Nonpolyposis Colorectal Cancer, Crohn’s Disease, Ulcerative Colitis) will be excluded from this 
review. Furthermore, the population of interest consists of those who are either not current 
with screening guidelines or have never had prior screening with FOBT, colonocospy, or 
sigmoidoscopy. The population also consists of all races and ethnicities; no limits were placed 
on nationality. Age range was limited to individuals over the age of 50.   
 The interventions of interest consist of education materials aimed at promoting 
colorectal cancer screening and knowledge amongst patients and not providers. These 
interventions include small media, defined as pamphlets, videos, books, other print materials, 
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and computer or Internet applications that explain colorectal cancer screening.  These media 
interventions should be designed to promote compliance elicit informed consent for a 
recommended option, or designed to not necessarily elicit a specific decision from a patient. 
These small media interventions can be viewed as “one-way” materials that do not seek to elicit 
feedback or engagement from the user. The other interventions include small media with 
decision aids. Decision aids are defined as interventions designed to help individuals make 
specific and deliberative choices among options by providing at minimum information on the 
options and outcomes relevant to the patient’s health.19 The comparators for these 
interventions is defined as “standard of care” that involves at the most, simple discussions with 
primary care providers concerning screening without any other informational interventions, or 
standard educational materials already in practice with regards to decision aids.  
 The outcomes of interest in this systematic review include patient knowledge, screening 
behaviors, and intent to become screened. Screening behaviors will be assessed with a decision 
to either undergo or forego screening after the intervention is administered. The time frame for 
such evaluations will be at least 1 month after administration. Patient intent will be determined 
based on subjective questionairres that can express patients desire to become screened. 
Patient knowledge will be assessed by an improvement in certain topics of information 
amongst each patient. Conversations about screening with providers will be based on either 
self-report or documentation in patient chart or notes. The time frame for all articles was 
limited to publication dates after 1996. The above PICOTSs are further expanded below in a 
discussion of exclusion/inclusion criteria and in Table 1
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Table 1: Inclusion and Exclusion Criteria for Final Review 
 Exclusion  Inclusion 
Study Design Research-based focus groups 
Observational trials, mixed 
methods studies, pre-post 
test interventions 
Randomized controlled trials  
 
 
 
Interventions Lifestyle interventions, 
education interventions 
aimed at treatment or 
diagnosis of cancer, group 
education, practice-level or 
physician-directed 
intervention, patient 
navigators, materials directed 
at other neoplasms 
Educational interventions 
including but not limited to 
multimedia, print materials, 
video, and electronic 
resources, and decision aids 
Study Population Individuals aged younger than 
50 years at higher than 
average risk for colorectal 
cancer (1st degree relatives 
with colorectal cancer, 
personal history of IBD, or 
hereditary conditions 
predisposing to CRC) 
Individuals between 50-75 at 
average risk for colorectal 
cancer, naïve screening 
population or patients not 
current with screening 
guidelines  
Study setting In-patient services, urgent 
care centers, emergency 
rooms 
Ambulatory care settings, 
outpatient clinics 
Comparators If a non-decision aid: usual 
care that includes other 
educational interventions, 
system or provider-level 
practices (physician 
reminders, EMR systems, 
patient facilitators) 
 
If decision aid: other decision 
aids as the ONLY comparator, 
practice level or provider level 
interventions as defined 
above 
Usual care: 
Defined for non-decision aid 
interventions as conversations 
with other providers or no 
additional intervention 
 
For decision-aids, can include 
other educational materials 
directed at patients, 
conversations with providers, 
or dummy interventions 
(educational videos on other 
topics not related to CRC 
screening) 
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Time Studies published before 1996 Any study published after 
1996.  
  
Data Sources  and Search Strategy  
 Medline was used to search for relevant studies and articles.. The search algorithm was 
limited to English-language articles published after 1996, with an age limited to middle aged 
individuals defined as aged 45 years and older. A review of the CINAHL database was also 
performed in conjunction with the initial MEDLINE search. Search limits were similar to those 
used in the MEDLINE search; all articles were limited to English-language, published after 1996, 
and mostly adults. Articles were also hand-searched for inclusion as well, especially with 
regards to recent articles that may have not appeared in the above searches. Such articles were 
published relatively recently in 2011, and thus did not necessarily have associated search terms 
that would be included in any current search strategy. Search algorithms for CINAHL and 
MEDLINE are included in Table 2 below. 
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Table 2: Search Algorithms for CINAHL and MEDLINE 
Database Algorithm 
MEDLINE ("prevention and control"[Subheading] OR ("prevention"[All Fields] AND "control"[All 
Fields]) OR "prevention and control"[All Fields] OR "prevention"[All Fields]) OR 
("mass screening"[MeSH Terms] OR ("mass"[All Fields] AND "screening"[All Fields]) 
OR "mass screening"[All Fields]) OR ("colonoscopy"[MeSH Terms] OR 
"colonoscopy"[All Fields]) OR (("feces"[MeSH Terms] OR "feces"[All Fields] OR 
"fecal"[All Fields]) AND ("occult blood"[MeSH Terms] OR ("occult"[All Fields] AND 
"blood"[All Fields]) OR "occult blood"[All Fields]) AND ("research design"[MeSH 
Terms] OR ("research"[All Fields] AND "design"[All Fields]) OR "research design"[All 
Fields] OR "test"[All Fields] OR "laboratory techniques and procedures"[MeSH Terms] 
OR ("laboratory"[All Fields] AND "techniques"[All Fields] AND "procedures"[All 
Fields]) OR "laboratory techniques and procedures"[All Fields])) OR 
("sigmoidoscopy"[MeSH Terms] OR "sigmoidoscopy"[All Fields])) AND (("rectal 
neoplasms"[MeSH Terms] OR ("rectal"[All Fields] AND "neoplasms"[All Fields]) OR 
"rectal neoplasms"[All Fields]) OR ("colonic neoplasms"[MeSH Terms] OR 
("colonic"[All Fields] AND "neoplasms"[All Fields]) OR "colonic neoplasms"[All Fields]) 
OR ("colonic neoplasms"[MeSH Terms] OR ("colonic"[All Fields] AND "neoplasms"[All 
Fields]) OR "colonic neoplasms"[All Fields] OR ("colon"[All Fields] AND "cancer"[All 
Fields]) OR "colon cancer"[All Fields]) OR ("colorectal neoplasms"[MeSH Terms] OR 
("colorectal"[All Fields] AND "neoplasms"[All Fields]) OR "colorectal neoplasms"[All 
Fields] OR ("colorectal"[All Fields] AND "cancer"[All Fields]) OR "colorectal cancer"[All 
Fields])) AND (("videotape recording"[MeSH Terms] OR ("videotape"[All Fields] AND 
"recording"[All Fields]) OR "videotape recording"[All Fields] OR "videotape"[All 
Fields]) OR ("pamphlets"[MeSH Terms] OR "pamphlets"[All Fields]) OR ("patient 
education as topic"[MeSH Terms] OR ("patient"[All Fields] AND "education"[All 
Fields] AND "topic"[All Fields]) OR "patient education as topic"[All Fields]) OR ("health 
education"[MeSH Terms] OR ("health"[All Fields] AND "education"[All Fields]) OR 
"health education"[All Fields]) OR ("multimedia"[MeSH Terms] OR "multimedia"[All 
Fields]) OR ("education"[Subheading] OR "education"[All Fields] OR "educational 
status"[MeSH Terms] OR ("educational"[All Fields] AND "status"[All Fields]) OR 
"educational status"[All Fields] OR "education"[All Fields] OR "education"[MeSH 
Terms]) OR ("patient acceptance of health care"[MeSH Terms] OR ("patient"[All 
Fields] AND "acceptance"[All Fields] AND "health"[All Fields] AND "care"[All Fields]) 
OR "patient acceptance of health care"[All Fields] OR ("patient"[All Fields] AND 
"acceptance"[All Fields] AND "healthcare"[All Fields]))) AND (("decision 
making"[MeSH Terms] OR ("decision"[All Fields] AND "making"[All Fields]) OR 
"decision making"[All Fields]) OR (Decision[All Fields] AND support[All Fields]). 
 
CINAHL (Preventive Health Care OR Cancer Screening OR colonoscopy OR FOBT OR 
Sigmoidoscopy) AND (Colonic Neoplasms OR Rectal Neoplasms OR Colon Cancer OR 
Colorectal Cancer) AND (Health knowledge OR Patient Education OR Print Materials 
OR Multimedia OR Video recording). 
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Quality Assessment  
 One reader reviewed abstracts in order to evaluate the articles for inclusion. Abstracts 
that described educational interventions for colorectal cancer were selected for full-text 
review. The full-text review was then performed in order to determine the final number of 
articles that would be included in the study based on pre-defined inclusion and exclusion 
criteria. These criteria were divided into four categories: study design, intervention type, study 
population, and study setting. For inclusion, the study design was pre-specified for randomized 
controlled trials only. Intervention type was specified as either a decision aid or small media 
education material (defined above) that promotes colorectal cancer screening. Study 
population was limited to individuals over 50 years old who were fit for screening and had no 
other co-morbidities that would preclude screening. Study sites were limited to ambulatory 
settings or outpatient clinics. Comparators were defined as usual care. 
 Exclusion criteria for the final review included any studies that were not randomized 
controlled. Articles that investigated other interventions (group education, system- or practice-
level changes, physician directed interventions (EMR reminder systems, etc), and patient 
facilitators or navigators) were also excluded from the study. Studies evaluating prevention 
amongst individuals with higher-than-average risk for colorectal cancer (inflammatory bowel 
disease, strong family history, previous personal history of colorectal cancer) were excluded. 
Finally, studies that were performed in settings where prevention techniques could potentially 
be used diagnostic tests (urgent care centers, inpatient services, emergency rooms) were 
excluded.  The exclusion and inclusion criteria are also summarized above in Table 1. 
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 Articles that met the inclusion criteria for final review were evaluated with quality 
criteria developed by the USPSTF and discussed in the Task Force’s Procedure Manual23 More 
specifically; interest was placed on assessing the overall internal validity and external validity of 
each article. Internal validity was determined by analyzing the composition of intervention and 
control groups, with particular emphasis placed on the maintenance of groups during the trial, 
accurate and reliable measurement methods, and adjustment for confounding. Internal validity 
was rated as good fair, and poor as specified and defined by the USPSTF. External validity was 
rated by assessing the study population, research situation, and providers involved in the study 
situation. External validity was rated globally, with similar indices as used for internal validity 
(good, fair, and poor).  
 A critical appraisal tool incorporating such criteria was developed by faculty affiliated 
with the University of North Carolina School of Medicine and the Gillings School of Global Public 
Health and was used for the purposes of quality abstraction.24  The critical appraisal tool 
assesses the above specifications of internal and external validity as defined by the USPSTF. The 
results of using this tool will be used to judge the overall quality of each article. All articles will 
be assessed via our interpretations of measurement bias, confounding, and selection bias. All 
three of these quality characteristics were graded on a scale of (+) to (+++), with (+) signifying 
low potential for bias and (+++) high potential. The potential for bias was then be used to judge 
the internal validity and external validity of each study. For the purposes of this review, we 
rated both internal and external validity as either poor, fair, or good. Overall quality of each 
study will be graded similarly to both internal and external validity. Reviewers completed the 
tool for each study in order to diminish the presence of measurement bias. The quality criteria 
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defined by the USPSTF and used in this review is listed in Table 3; the critical appraisal tool used 
for our review is included in Table 4. 
 
Data Extraction and Outcomes Evaluation 
 This systematic review is interested in a number of outcomes, related to patient-
directed educational interventions and their role in promotion of colorectal cancer screening. 
For the purposes of this review, primary outcomes consisted of patient knowledge, patient 
intent, and screening uptake. Patient knowledge is defined as an understanding of colorectal 
cancer as well as methods of screening. Knowledge should also include an understanding of 
average risk for colorectal cancer in addition to the risks and benefits of screening methods. 
Patient intent is defined as the desire to undergo screening. Screening uptake is defined as the 
proportion of intervention or controls who have taken up screening after viewing the decision 
aid. Screening uptake will most likely be assessed either by chart review or patient admission.  
 The outcomes of screening intent and knowledge will most likely employ different 
evaluation tools across multiple studies. Some studies may have adopted standardized 
questionnaires while others employ novel de novo methods for evaluation. In addition, 
reporting of outcomes will most likely differ by study. Because of these disparities in reporting 
and in different evaluation tools, a meta-analysis was not performed for overall data analysis.  
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 Internal Validity External Validity 
Critieria  Initial assembly of comparable groups:  
o For RCTs: adequate randomization, including first 
concealment and whether potential confounders were 
distributed equally among groups. 
o For cohort studies: consideration of potential 
confounders with either restriction or measurement 
for adjustment in the analysis; consideration of 
inception cohorts. 
 Maintenance of comparable groups (includes attrition, cross-
overs, adherence, contamination). 
 Important differential loss to follow-up or overall high loss to 
follow-up. 
 Measurements: equal, reliable, and valid (includes masking of 
outcome assessment). 
 Clear definition of interventions. 
 All important outcomes considered. 
 Analysis: adjustment for potential confounders for cohort 
studies, or intention to treat analysis for RCTs. 
Study Population: 
The degree to which the people who were involved as subjects in the study constitute 
a special population because they were selected from a larger eligible population or 
were for other reasons unrepresentative of people who are likely to seek or be 
candidates for the preventive service. The selection has the potential to affect the 
following: 
 Absolute risk: The background rate of outcomes in the study could be 
greater or less than what might be expected in asymptomatic people because 
of the inclusion/exclusion criteria, because of non-participation, or for other 
reasons. 
 Harms: The harms observed in the study could be greater or less than what 
might be expected in asymptomatic people. 
The following are features of the study population and the study design that may 
cause experience in the study to be different from what would be observed in the US 
primary care population: 
 Demographics (age, gender, ethnicity, education, income): The criteria for 
inclusion/exclusion or non-participation do not encompass the range of 
people likely to be candidates for the preventive services in the US primary 
care population. 
 Co-morbidities: the frequency of co-morbid conditions in the study 
population does not represent of the frequency likely to be encountered in 
people who seek the preventive service in the U.S. primary care population. 
 Special inclusion/exclusion criteria: There are other special 
inclusion/exclusion criteria that make the study population unrepresentative. 
 Refusal rate (ratio of included to not-included but eligible participants): The 
refusal rate among eligible study subjects is high, making the enrollees in 
the study unrepresentative even of the people eligible for the study. 
 Adherence (run-in phase, frequent contact to monitor adherence): The 
design of the study has features that may make the effect of the intervention 
in the study greater than it would be in a clinically observed population. 
 Stage in natural history of disease; severity of disease: the selection of 
subjects for the study includes people with at a stage that is earlier or later 
than would be found in people who are candidates for the preventive 
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service. 
 Source, intensity of recruitment: The sources for recruiting subjects for the 
study and/or the effort and intensity of recruitment may distort the 
characteristics of the study subjects in ways that could increase the effect of 
the intervention as it is observed in the study. 
Situation: 
The degree to which the clinical experience in the situation in which the study was 
conducted is likely to be reproduced in other settings 
 Healthcare system: The clinical experience in the system in which the study 
was conducted is not likely to be the same as experience in other systems 
because, for example, the system provides essential services for free when 
these services are only available at a high cost in other systems. 
 Country: The clinical experience in the country in which the study was 
conducted is not likely to be the same as in the U.S. because, for example, 
services available in the U.S. are not widely available in the other country of 
study conduct or vice versa. 
 Selection of participating centers: The clinical experience in which the 
study was conducted is not likely to be same as in offices/hospitals/settings 
in which the service will be delivered to the U.S. primary care population 
because, for example, the centers have ancillary services not available 
generally. 
 Time, effort, and system cost for the intervention: The time, effort, and cost 
to develop the service in the study is more than would be available outside 
the study setting. 
Providers: 
The degree to which the providers in the study have the skills and expertise likely to 
be available in general settings 
 Training to implement the intervention: The intervention in the study was 
done after giving providers special training not likely to be available or 
required in U.S. primary care settings. 
 Expertise, skill to implement intervention: The providers included in the 
study had expertise and/or skills at a level that is higher than the level likely 
to be encountered in typical settings. 
 Ancillary providers: The study intervention relied on ancillary providers 
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Table 3: Quality Criteria for Internal and External Validity – USPSTF Procedure Manual 
who are not likely to be available in typical settings. 
 
Ratings Good: Meets all criteria: Comparable groups are assembled initially 
and maintained throughout the study (follow-up at least 80 percent); 
reliable and valid measurement instruments are used and applied 
equally to the groups; interventions are spelled out clearly; all 
important outcomes are considered; and appropriate attention to 
confounders in analysis. In addition, for RCTs, intention to treat 
analysis is used. 
Fair: Studies will be graded "fair" if any or all of the following 
problems occur, without the fatal flaws noted in the "poor" category 
below: Generally comparable groups are assembled initially but some 
question remains whether some (although not major) differences 
occurred with follow-up; measurement instruments are acceptable 
(although not the best) and generally applied equally; some but not all 
important outcomes are considered; and some but not all potential 
confounders are accounted for. Intention to treat analysis is done for 
RCTs. 
Poor: Studies will be graded "poor" if any of the following fatal flaws 
exists: Groups assembled initially are not close to being comparable or 
maintained throughout the study; unreliable or invalid measurement 
instruments are used or not applied at all equally among groups 
(including not masking outcome assessment); and key confounders are 
given little or no attention. For RCTs, intention to treat analysis is 
lacking. 
 
Good: The study differs minimally from the US primary care 
population/situation/providers and only in ways that are unlikely to affect the 
outcome; it is highly probable (>90%) that the clinical experience with the 
intervention observed in the study will be attained in the US primary care setting. 
 
Fair: The study differs from the US primary care population/situation/providers in a 
few ways that have the potential to affect the outcome in a clinically important way; 
it is only moderately probable (50%-89%) that the clinical experience with the 
intervention in the study will be attained in the US primary care setting. 
 
Poor: The study differs from the US primary care population/ situation/ providers in 
many way that have a high likelihood of affecting the clinical outcomes; the 
probability is low (<50%) that the clinical experience with the intervention observed 
in the study will be attained in the US primary care setting. 
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Name: 
PUBH 751: Critical Appraisal of the Health Literature 
Citation (JAMA style)  
 
Study Question and  Research Design  
Source Population  
 
Study Population (descriptive: demographics, eligibility 
criteria) and how chosen (volunteers, recruitment, tertiary care 
clinics, population-based, etc) 
 
 
Initial Comparability of groups (ie, randomization or group 
composition; concealment of allocation) 
 
 
 
Drop outs (no endpoint data), adherence, crossovers (attrition, 
loss to follow up) 
 
Potential for selection bias (+ to +++) and explain  
 
 
Measurement of exposure, intervention, potential confounders, 
and outcomes; reliability and  
 
validity of measurement; how performed, blinding 
 
Potential for measurement bias (+ to +++)  
 
 
Potential confounders (name and describe how each was 
controlled for) 
 
 
 
Potential for confounding (+ to +++)  
 
 
Analysis (intention to treat or other adjustment)  
Results: magnitude and direction (point estimate; random error 
or precision (confidence interval); statistical significance 
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Table 4: Critical Appraisal Tool – Gillings School of Global Public Health and the UNC School of Medicine 
 
 
 
 
 
 
 
 
 
Clinical and Public Health importance for the source 
population; for a wider population 
 
Overall judgment of internal validity (good, fair, poor)  
External validity: applicability to other populations  
Comments and overall conclusions/interpretation (include 
consistency with other studies; biologic plausibility; conflicts 
of interest; selective endpoint reporting) 
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Results 
 The initial search strategy yielded 118 articles from MEDLINE, 107 articles from CINAHL, 
and 2 articles from hand searching. The overall search yielded 225 distinct articles when 
excluding two instances of duplicate articles. All 225 abstracts were reviewed, yielding a total of 
32 articles included in the full-text review and 193 article exclusions. Of the 30 articles text 
reviewed, a total of 8 articles met the criteria for final inclusion and 19 for exclusion. Of the 19 
articles that were excluded, 47% were not randomized-controlled, 32% evaluated interventions 
other than those targeted for this review, and 21% were studies that involved the wrong type 
of population. Three articles could not be full-text reviewed due to the fact that they were 
unavailable in the library of our institution and were thus not included in our study. Our search 
strategy and review process are included in the Figure 1 below.  
 Of the eight articles selected for final review, 7 were randomized controlled trials 
evaluating colorectal cancer screening decision aids and 1 was a randomized controlled trial 
evaluating a small media educational intervention video that was not a decision aid. A 
description of included articles is listed in Table 5. With regards to our primary outcomes of 
interest, seven out of eight articles (88%) reported screening uptake results; 3 out of 8 studies 
(38%) reported knowledge as a pre-specified outcome; 4 out of 8 studies (38%) reported 
patient intent or readiness for screening as an outcome. All eight articles were assessed for 
quality using our two evaluation tools. The results of the quality assessment are highlighted in 
Table 7. Seven out of six articles received a quality rating of “good” while only one article 
received a quality rating of fair. No articles were given a rating of poor. 
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Figure 1: Flow Diagram of Search Strategy and Review Process 
 
 
 
 
Original Search Total – 227 
MEDLINE – 118 abstracts 
CINAHL – 107 abstracts 
Hand searching – 2 abstracts 
Abstract Review Led to 197 Exclusions: 
Duplicates, other neoplasm screening (breast, 
prostate, cervical), non-educational 
interventions, high risk population decision 
support, duplicates (n=2) 
 
Identified for Full Text Review – 32 
Medline – 17 articles 
CINAHL  - 13 articles 
Hand-Searching – 2 articles 
 
Final Inclusion – 8 articles 
MEDLINE – 5 articles 
CINAHL – 1 article 
Hand-Searching – 2 articles 
 
Exclusions – 19 articles 
9 Non –RCT 
6 Different 
Intervention 
4 Different Population 
 
 
Unavailable – 3 articles 
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Table 5: Characteristics/Description of Studies Included in Final Review 
Study  Study Type Research Objective Intervention and Control  Study 
Population  
 
Outcomes of interest 
Pignone M, Harris R, 
Kinsinger L (2000)
25
  
Randomized-
Controlled Trial 
To test whether a decision aid 
consisting of an educational video, 
targeted brochure, and chart 
marker increased performance of 
colon cancer screening in primary 
care practices.  
Intervention Arm: 
11 minute video on colon cancer, 
followed by an exercise in which 
participants are asked to choose one 
of three color-coded, patient-
directed brochures to indicate their 
interest in screening; color-coded 
card was attached to patient chart. 
 
Control 
A video of similar length on car 
safety, seat belt use, and airbags, 
and received a standard brochure on 
automobile safety. 
Total study 
population, n = 
249 
 
Intervention arm  
125  
 
Control Arm 
124 
 
-Intent to ask provider about 
screening 
-Conversations about screening,  
-Screening test ordering, 
-Screening test completion or 
uptake 
Smith SK, Trevena L, 
Simpson JM (2010)
26 
Randomized-
Controlled Trial 
 Whether a decision aid designed 
for adults with low education and 
literacy can support informed 
choice and involvement in 
decisions about screening for 
bowel cancer 
Interventions:  
Two interventions arms consisting of 
a decision aid (paper based booklet 
and DVD) with or without a question 
prompt list 
 
Control:  
The consumer information booklet 
developed for people invited to take 
part in the Australian national bowel 
cancer screening program.  
 
 
 
Total Study 
population, n = 
572 
 
Intervention 
Arms
* 
Total = 384 
-Decision Aid w/ 
question propmpt 
list = 196 
-Decision aid w/o 
question prompt 
= 188 
These two groups 
were combined in 
final analysis 
 
Control  
173 
Primary outcomes  
-Informed choice 
-Knowledge  
-Screening attitudes and behaviors  
 
Secondary outcomes  
-decisional conflict  
-decision satisfaction 
-confidence in decision-making  
-general anxiety   
-interest in screening  
-worry about developing bowel 
cancer 
-acceptability of materials. 
Trevena LJ, Irwig L, 
Barratt A (2008)
27
 
Randomized-
controlled trial.  
Test the effect of a self-
administered decision aid on 
informed choice in participants 
Intervention: 
Decision aid booklet; six booklets 
were produced, each containing age, 
Total study 
population, n= 
314 
Primary Outcomes 
-informed choice   
-integrated decisions  
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from a range of educational 
backgrounds, and to assess 
whether their decisions are 
consistent with values about 
screening.  
 
gender, and family history-specific 
probabilities of the outcomes of 
biennial FOBT-screening over five 
screening rounds. Included five core 
issues for informed choice about 
screening.  
 
Control:  
Consumer print materials version of 
Australia guidelines for colorectal 
cancer screening 
 
 
Intervention Arm 
n = 157 
 
Control Arm 
n = 157 
(defined by three measures: 1). 
Adequate knowledge 2), clear 
values and 3). Screening intention) 
 
Secondary Outcomes 
-Screening test uptake 
- decision aid acceptability 
-psychological outcomes 
 
  
 
Ruffin MT,4th, Fetters 
MD, Jimbo M (2007)
28 
Randomized 
controlled trial  
To test a preference-based 
decision aid for colorectal cancer, 
and sought to test it against stand-
alone website. The intervention is 
called “Colorectal Web” 
Intervention: 
Colorectal Web, interactive program 
presented as a web site or stand-
alone program, includes a 
preference clarification activity 
 
Control: 
an existing CRC Web site carefully 
selected by investigators as 
reflecting the standard, state of the 
art, non-interactive format. Differs 
from Colorectal Web in that it does 
not promote a preference among 
the CRC screening options. 
Total Study 
population, n = 
174 
 
Intervention Arm 
n = 87 
 
Control Arm 
n = 87 
Primary Outcomes 
-Screened for colorectal cancer 
 
Secondary Outcomes 
-Screening test preference 
Dolan JG, Frisina S 
(2002)
29 
Randomized-
Controlled Trial  
Conduct a pilot test of a decision 
aid designed to help patients 
choose among currently 
recommended colorectal cancer 
screening programs.  
 
Intervention: A 2 part process, 
consisting of a preliminary phase and 
the administration of a decision aid. 
The decision aid consisted of a 
model that incorporated aspects of 
the analytic hierarchy process.  
 
Control: Standardized interview 
consisting of a preliminary phase and 
an educational phase. Preliminary 
phase consisted of brief description 
of colorectal cancer and the purpose 
of the study, a demographic survey, 
questions regarding family and 
personal history, etc. Educational 
Total study 
population, n = 97 
patients 
 
Intervention Arm 
n = 50 
 
Control Arm 
n = 47 
Primary Outcome 
-Decision process  
-Decision outcome (screening 
uptake) 
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phase was a short 470-word 
description of colorectal cancer and 
descriptions of the 5 screening 
programs 
 
 
Miller DP,Jr, Spangler 
JG, Case LD et al. 
(2011)
30 
Randomized 
controlled trial 
Determine if a web-based 
multimedia colorectal cancer 
screening patient decision aid, 
developed for a mixed-literacy 
audience, could increase CRC 
screening 
Intervention: CHOICE CRC screening 
decision aid (Communicating Health 
Options through Interactive 
Computer Education); based on 
video-tape decision aid developed by 
Pignone, Harris, and Kissinger 
(2000)
25 
 
Control: A video about prescription 
refills and drug safety.  
 
 
Total study 
population, n = 
264 enrolled 
 
Intervention arm 
n = 132 
 
Control arm 
n = 132 
Primary Outcome 
-Receipt of CRC screening within 
24 weeks of study enrollment.  
 
Secondary Outcome 
-patient’s ability to state a CRC 
screening preference,  
-patient’s change in readiness to 
receive CRC screening,  
-CRC test ordering a visit 
immediately following the 
assigned program 
 
Schroy PC,3rd, Emmons 
K, Peters E, et al 
(2011)
31 
Randomized 
controlled trial 
Assess the effectiveness of a novel 
decision aid on shared decision-
making in the primary care setting.  
Intervention: Intervention is an 
interactive computer-based decision 
aid. 2 intervention arms were 
created: one with a decision aid plus 
a YDR personalized risk assessment 
tool with feedback or the decision 
aid alone, or control arm. 
 
Control: a modified version of “9 
ways to stay healthy and Prevent 
Disease” website 
Total study 
population, n = 
666 
 
Intervention Arm: 
Two arms: 
Decision aid plus 
YDR risk 
assessment 
(n=223) 
 
Decision aid alone 
(n=212) 
 
Control Arm: 
 n = 231 
Primary Outcome 
-patient knowledge 
-patient preferences 
-satisfaction with the decision-
making process 
-screening intentions, and test 
concordance 
Zapka JG, Lemon SC, 
Puleo, E, et al. (2004)
32
 
Randomized 
Controlled Trial  
Test the effectiveness of a video 
(educational) designed to improve 
colorectal cancer screening uptake 
Intervention: Educational video that 
seeks to encourage patients to speak 
to their health care providers about 
colorectal cancer screening, namely 
sigmoidscopy. It is a 15 minute video 
titled “Say Yes to the Test.”  
Total study 
population, n = 
938 
 
Intervention Arm 
n = 450 
Primary Outcome: 
-colorectal cancer screening at 
follow-up. 
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Control: Usual care 
 
 
Control Arm 
n = 488 
* Smith SK, Trevena L, Simpson JM, et al. combined the two intervention arms for the final analysis.   
 
 
Table 6: Quality Assessment of Articles Included in Final Review 
Article CONSORT 
Criteria fulfilled 
Selection 
Bias 
Measurement 
Bias 
Confounding Bias Internal Validity External Validity Overall Quality 
Pignone M, Harris 
R, Kinsinger L 
(2000)
25 
 
+ + + Good Good Good 
Smith SK, Trevena 
L, Simpson JM 
(2010)
26 
 
+ ++ + Good Good Good 
Trevena LJ, Irwig L, 
Barratt A (2008)
27 
 + ++ + Good Good Good 
Ruffin MT,4th, 
Fetters MD, Jimbo 
M (2007)
28 
 
+ ++ + Good Good Good 
Dolan JG, Frisina S 
(2002)
29 
 + ++ + Good Good Good 
Miller DP,Jr, 
Spangler JG, Case 
LD et al. (2011)
30 
 
+ ++ + Good Good Good 
Schroy PC,3rd, 
Emmons K, Peters 
E, et al (2011)
31 
 
++ +++ +++ Fair Fair Fair 
Zapka JG, Lemon 
SC, Puleo, E, et al. 
(2004)
32
 
 
++ ++ + Good Fair Good 
 
 
28 | P a t e l  
 
Colorectal Cancer Screening Uptake 
 A majority of the articles evaluated colorectal cancer screening uptake as a pre-specified 
outcome.  Pignone M, Harris R, and Kinsinger L (2000)25 measured screening test uptake via 
patient chart review. They report that 36.8% of intervention subjects completed a screening 
test versus 22.6% of controls with an absolute difference of screening of 14.2% (95% CI 3.0-
23.4%) favoring the intervention group. The unadjusted relative risk of having a screening test 
ordered after watching an intervention was 1.79 (95% CI 1.23-2.58) compared to controls.  
 Smith SK, Trevena L, Simpson JM (2010)26 evaluated screening uptake three months 
post-intervention from patient test completion records. Fecal Occult Blood Test (FOBT) kits 
were mailed to all participants. Overall 68% of the entire study cohort had completed and 
returned the FOBT test kits. When examined by intervention, 59% of participants in the 
intervention had completed the FOBT compared to 75% of controls (P<0.01).  
 Trevena LJ, Irwig L, Barratt A (2008)27 determined screening rates amongst participants 
one month after having viewed or received the intervention. This was determined via 
telephone. After one month, the proportion of decision aid participants who had reported 
completion of the FOBT was 5.5% compared to 6.6% of controls (p=0.64). This difference was 
reported as not statistically significant.  
 Ruffin MT,4th, Fetters MD, Jimbo M (2007)28 also evaluated screening uptake by 
questioning participants via telephone interviews at 2,8, and 24 weeks after using Colorectal 
Web, a multimedia web-based decision aid. They found that at 24 weeks post-intervention, a 
total of eighty-nine participants had been screened; 56 in the intervention arm and 33 in the 
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control arm for an absolute difference of 23 (p=0.035). The odds ratio for screening based on 
the exposure to the decision aid (using logistic regression) was 3.23 (95% CI 2.73-3.50).  
 Dolan JG, Frisina S (2002)29 assessed screening uptake or decision outcome via chart 
review 2 to 3 months after participants completed study visit. The authors state that data 
extraction included whether colorectal cancer screening was documented in the visit note, the 
specific screening test chosen, whether the screening test was completed, and the results of 
screening and follow-up examinations. The authors found that 14 individuals in the control 
group (52%) had completed screening compared to 18 (49%) in the experimental group (p = 
1.0). The authors concluded that there was no statistical difference in the proportion of those 
getting screened based on intervention status.  
 Miller DP,Jr, Spangler JG, Case LD et al. (2011)30 evaluated receipt of CRC screening 
within 24 weeks of study enrollment via chart review. Both the ordering of a screening test as 
well as receipt were extracted. Amongst individuals who viewed the Communicating Health 
Options through Interactive Computer (CHOICE) screening decision aid, 19% completed the test 
at 24 weeks. As a comparator, the proportion of control subjects who completed screening was 
14% (p=0.25). The odds ratio for having a screening test with the CHOICE decision aid as an 
exposure was 1.7 (95% CI 0.8-3.2, p=0.12). The authors concluded there was no statistically 
significant difference in screening completion between the intervention and control groups.  
 Zapka JG, Lemon SC, Puleo, E, et al. (2004)32 measured screening completion amongst 
individuals randomized to view a non-decision aid educational video and amongst individuals 
who had received regular care without special instruction or media. They evaluated patient 
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screening receipt via telephone interviews administered 4 to 6 months after initial study visit. In 
total, 55% of participants reported current testing, with 90% reported for the purposes of 
screening (colonoscopy was excluded). Amongst the control group, 55.3% reported having a 
sceening test of any type compared to 55.1% of subjects who were randomized to view the 
video. The authors delineate their results based on the screening test; the odds ratio with the 
video as the exposure for getting screened with sigmoidoscopy with or without another test 
was 1.22 (95% CI 0.88-1.70) while the odds ratio for other test combinations was 0.84 (0.63-
1.14). The authors concluded that there was no overall increase in screening rates due to the 
educational video.  
 The outcomes for screening uptake for colorectal cancer are summarized in Table 7.  
 
Patient Knowledge of Colorectal Cancer Screening 
 Three out of eight articles pre-specified patient knowledge as an outcome of interest. 
Smith SK, Trevena L, Simpson JM (2010)26 were interested in patient knowledge as a component 
of informed choice in the decision-making process. The author’s measure of knowledge was 
developed by the UK General Medical Council guidelines relating to screening. The measure 
assessed both conceptual and numerical knowledge of colorectal cancer and screening. A 
marking scheme was developed that provided a max score of 12 (4 points for questions related 
to conceptual understanding and 8 points for numerical knowledge. Investigators decided that 
50% or a score greater than or equal to 12 was considered “adequate knowledge”. These scores 
were dichotomized into adequate and inadequate knowledge. Conceptual knowledge improved 
significantly in both groups before and after the intervention, with a mean increase of 1.20 in 
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the decision aid groups and 1.26 in the control group (p<0.001). The proportion of participants 
with adequate knowledge total knowledge was higher in the decision aid group (56%) than in 
the control group (19%) (p<0.001). The decision aid also increased participants’ numerical 
understanding of basline risk for colorectal cancer as well as absolute reduction in deaths 
attributable to screening: the mean scores were 2.93 (maximum of 8) for intervention group 
and 0.58 for the control group (p<0.001).  
 Trevena LJ, Irwig L, Barratt A (2008)27assessed knowledge via responses to four open-
ended questions regarding FOBT. Patients were judged on the basis of these questions as to 
whether or not they had adequate or inadequate knowledge. The knowledge assessment was 
used as in order to determine the authors’ larger outcome of interest concerning informed 
choice. Among those who had viewed the decision aid, 20.9% were deemed to have adequate 
knowledge compared to 5.5% of those exposed to the control guidelines (p=0.0001).  
 Schroy PC,3rd, Emmons K, Peters E, et al (2011)31 assessed knowledge at baseline and 
after viewing the intervention. The measure used to evaluate knowledge was adapted from key 
messages endorsed by the National Colrectal Cancer Raoundtable and the Massachusetts 
Department of Public Health. The measure consisted of a 12-item true-false questionnaire that 
inquired about risk factors for colorectal cancer, the purposes for colorectal cancer screening, 
and the age at which screening should begin. Cumulative knowledge scores were derived by 
summing the total number of correct responses, from a scale of 0 to 12. Baseline knowledge 
scores for the two decision aid groups (decision aid alone or decision aid + personalized risk 
assessment) were similar to the control group [decision aid plus YDR: 7.5 (SD 2.8); decision aid 
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alone: 7.7 (SD 2.9); control 7.5 (2.7)]. Post-test scores were 10.7 (SD 1.8) for the decision aid 
plus YDR, 10.9 (SD 1.6) for the decision aid alone, and 8.6 (SD 2.6) for the control group. The 
mean increase in scores was 3.0 (SD 2.5) for the decision aid alone group and 3.3 (SD 2.6) for 
the decision aid plus YDR group, compared to the control group’s mean score increase of 0.8 
(SD 2.2) (p<0.001).  
 The overall results for the above studies are summarized in Table 7.  
 
Patient Intent Towards Screening 
 A total of three articles discussed patient intent for screening as a pre-specified 
outcome. The studies investigating patient intent were Smith SK, Trevena L, Simpson JM 
(2010)26, Trevena LJ, Irwig L, Barratt A (2008)27 ,  Miller DP,Jr, Spangler JG, Case LD et al. 
(2011)30, and Schroy PC,3rd, Emmons K, Peters E, et al (2011)31. 
 Smith SK, Trevena, L, Simpson JM (2010)26 were interested in determining attitudes 
toward completing FOBT and measured this using a six item scale. Scores ranged from 6 to 30 
with higher scores signifying a more positive attitude towards completing the test. The authors 
used the median value of the sample in order to classify participants’ attitudes as positive or 
negative. Participants in the decision aid groups had mean score of 26.4 towards completing 
FOBT compared to a mean score of 27.3 for the control group (p=0.003). The authors concluded 
that participants in the decision aid groups were more likely to have a negative attitude 
towards completing FOBT.   
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 Trevena LJ, Irwig L, Barratt A (2008)27 assessed intention to screen in a questionnaire 
immediately after viewing the decision aid or control. Intention was used as a proxy for 
screening decisions and was measured at baseline as well. At baseline, 90.4% of individuals 
randomized to the decision aid group intended to pursue screening compared to 88.5% of the 
participants randomized to the guidelines. At post-test, given imeediately after subjects were 
exposed to either the control guidelines or the printed decision aid, 87.3% of decision aid 
participants reported intent to pursue screening compared to 90.5% of controls (p = 0.40). 
Furthermore, the authors reported that 21.6% of participants randomized to the decision aid 
reported that the intervention shifted their intention “away” from screening compared to 
22.6% of controls (p=0.48). The authors stated that these were not statistically significant.  
 Miller DP,Jr, Spangler JG, Case LD et al. (2011)30 reported “readiness to screen” as a pre-
specified outcome. Readiness to receive screening was measured at baseline and after viewing 
the respective computer programs (either the CHOICE decision aid or control program) with 
two identical questions: 1) are you interested in being screened for colon cancer in the next 
three months 2) Do you plan to ask your doctor about being screened for colon cancer at this 
visit?  Patient responses to these question were then used to map each patient’s pre-action 
readiness stage using the TransTheoretical Model’s Stages of Change. The stages were 
Precontemplation (no interest in screening within the next three months), Contemplation 
(unsure if interested in screening but planning to discuss screening at visit or interest in being 
screened but not at this visit), and Preparation for Action (interested and plan to discuss 
screening immediately).33 Approximately half of patients entered the study at the Preparation 
for Action stage and thus could not increase their intent for screening. Among patients who 
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were at the Precontemplation or Contemplation stage, 52% of those who were randomized to 
the CHOICE decision aid moved to a more favorable stage compared to 20% of those who were 
in the control group (p=0.0001). Six CHOICE patients and one control patient moved to less 
favorable stages. The authors state the odds ratio of having increased readiness when exposed 
to the decision aid was 4.7 (95% CI 1.9-11.9) when compared to controls.  
 Schroy PC,3rd, Emmons K, Peters E, et al (2011)31 asked participants about screening 
interventions immediately after viewing the decision aid and control. Subjects were asked how 
sure they were to schedule an appointment to get screened for CRC and how sure were they to 
complete the screening. Responses were graded on a 5-point frame ranging from “not all sure” 
to “completely sure”. Mean intention scores for the question, “How sure are you that you will 
schedule a colorectal cancer screening test?” were 4.3 (SD 1.0) in the decision aid plus risk 
assessment group, 4.4 (SD 1.0) in the decision aid group alone, and 3.9 (1.4) in the control 
group. Mean intention scores for the question of how sure they were to complete screening 
were 4.3 (SD 1.0) for both intervention groups and 3.9 (1.3) for the control group.  
 All the results for screening intentions are summarized below in Table 7. 
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Table 7: Results of Primary Outcomes  
Article Screening Uptake Knowledge Intent 
Numerical Results Effect of 
Intervention 
Numerical Results Conclusion Numerical 
Results 
Conclusion 
Pignone M, Harris R, 
Kinsinger L (2000)
25 
Test completion: 36.8% of 
intervention subjects vs. 22.6% 
controls, absolute difference of 14.2% 
(3.0-23.4%) favoring intervention 
group 
 
Unadjusted RR 1.79 (1.23-2.58) 
Positive 
    
Smith SK, Trevena L, 
Simpson JM (2010)
26 
68% of entire cohort completed FOBT 
 
59% of intervention completed FOBT 
compared to 75% of controls 
(p<0.01).  Negative 
 56% of those viewing 
the decision aid had 
adequate knowledge 
compared to 19% of 
controls (p<0.001). Positive 
Median readiness 
score for 
completion of 
screening:  
 
Intervention group 
26.4 vs. control 
group 27.3 
(p=0.003) 
.   
Negative 
Trevena LJ, Irwig L, 
Barratt A (2008)
27 
5.5% of those who viewed the 
intervention vs. 6.6% of controls 
(p=0.64) 
No effect 
20.9% of the decision aid 
group had “adequate 
knowledge” versus 5.5% 
of control group 
Positive Intention to pursue 
screening: 
87.3% of decision 
aid participants vs. 
90.5% of controls 
(p=0.40) 
 
No effect 
Ruffin MT,4th, 
Fetters MD, Jimbo M 
(2007)
28 
89 pateints total been screened: 56 in 
the intervention arm vs. 33 in the 
control arm for an absolute difference 
of 23 (p=0.035)  
 
Odds ratio for test completion, using 
logistic regression to control for 
demographic or physician 
Positive 
  Amongst those at 
Contemplation or 
Precontemplation: 
 
52% of those who 
were randomized 
to the CHOICE 
decision aid moved 
No effect 
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characteristics = 3.23 (2.73-3.50) to a more favorable 
stage compared to 
20% of those who 
were in the control 
group (p=0.0001). 
 
OR of increased 
readiness = 4.7 
(1.9-11.9) 
Dolan JG, Frisina S 
(2002)
29 
14 in control group (52%) versus 18 
(49%) in experimental group (p=1.0) No effect 
    
Miller DP,Jr, Spangler 
JG, Case LD et al. 
(2011)
30 
19% of intervention group completed 
screening versus 14% of controls 
(p=0.25) 
Odds ratio for completion of 
screening: 1.7 (0.8-3.2, p=0.12) No effect 
The mean increase in 
knowledge scores 3.0 
(SD 2.5) for the decision 
aid alone group and 3.3 
(SD 2.6) for the decision 
aid plus YDR group, 
compared to the control 
group’s mean score 
increase of 0.8 (SD 2.2) 
(p<0.001). 
Positive   
Schroy PC,3rd, 
Emmons K, Peters E, 
et al (2011)
31 
 
 
  Mean intention 
scores for 
scheduling 
screening: 4.3 (1.0) 
for DA + YDR, 4.4 
(1.0) in DA alone, 
3.9 (1.4) in control 
group.  
 
Mean intention for 
completion of 
screening: 4.3 (1.0) 
for both 
interventions (DA 
or DA + YDR) 
compared to 3.9 
(1.3) for controls 
Positive 
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Zapka JG, Lemon SC, 
Puleo, E, et al. 
(2004)
32
 
55.3% of controls reported having 
screening of any type compared to 
55.1% of controls 
 
OR for completing sigmoidoscopy 
with or w/o any other test: 1.22 (0.88-
1.70) 
 
OR for any other test combination: 
0.84 (0.63-1.14) 
No effect 
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Discussion 
 Our systematic review includes eight randomized controlled trials evaluating the effects 
of educational interventions (decision aids and small media) on outcomes associated with a 
patient’s decision to pursue screening for colorectal cancer. The review included seven 
randomized controlled trials evaluating decision aids and one randomized controlled trial 
evaluating a non-decision aid educational video.  
 Overall, the majority of studies were rated good (88%) with only one study rated as fair. 
Seven of eight studies evaluated the outcome of screening uptake. Overall, the evaluated the 
studies demonstrated a mixed effect with regards to overall uptake of screening. Only two 
articles demonstrated a positive effect with screening while four studies showed no effect of 
the educational intervention and screening rates. One study even showed a negative trend with 
regards to screening. Patient knowledge was also assessed, but only three studies specified 
knowledge as an outcome of interest. All three studies demonstrated a positive effect of the 
intervention on increasing knowledge of colorectal cancer and screening. Four articles specified 
patient intent to pursue screening as a pre-specified outcome; only one study demonstrated a 
positive effect with regards to an intervention’s effect on intent while two articles showed no 
change in intent and one demonstrated a negative effect on intent for screening.  
 Based on these findings, we conclude that good quality evidence suggests mixed effects 
of educational interventions in improving screening uptake and patient intent. Good quality 
studies demonstrate a positive effect on educational interventions and improvement in patient 
knowledge. The small number of articles reviewed limits the applicability of our conclusions, 
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and thus we conclude that overall, the evidence rating the effectiveness of educational 
interventions is currently insufficient.   
 Our findings fit with a previous systematic review seeking to summarize evidence on 
factors and strategies that could influence colorectal cancer screening. The review investigated 
patient-level interventions and analyzed such interventions based on type. Small medial with 
and without decision aids was reviewed. The evidence for small media with decision aids was 
rated as low, and was found to have mixed effects with regards to screening, with an 
improvement of rates from -6% to 15%. Small media without decision aids was rated as high in 
regards to strength of evidence and also had mixed effects, with changes in screening 
documented at between -3 to 23%. This is similar to our conclusions of the mixed effects of 
educational interventions on screening rates.  A Cochrane review evaluating randomized 
controlled trials of decision aids investigated patient knowledge as an outcome. The study 
concluded that overall, decision aids produced higher knowledge scores, with a mean 19% 
improvement from baseline. Our findings, although limited, thus support this finding. To our 
knowledge, no evidence exists evaluating the change in patient intent or attitudes towards 
screening.  
 Our review demonstrates that evidence exists evaluating educational interventions in 
randomized-controlled settings. We suggest that more research is needed to investigate 
colorectal cancer education materials, especially given the lack of time available in outpatient 
settings to adequately counsel patients in informed decision making as well as the low rates of 
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colorectal cancer screening in general.  Furthermore, improving lower rates of health literacy 
have been highlighted by the Institute of Medicine.  
 Our review has a number of limitations. First, we decided to limit our review to study 
designs of randomized controlled trials. A large number of studies evaluating educational 
interventions employed a pre-test/posttest design, in which a cohort was exposed to the 
intervention and tested afterwards. We thus excluded a number of studies on this basis that 
may have limited our ability to make valid conclusions with regards to our outcomes of patient 
knowledge and patient intent. Second, our review excluded any studies that incorporated other 
types of interventions in addition to simple educational interventions. For example, one study 
evaluated a multi-level intervention, with a decision-aid coupled with provider training and 
practice level interventions; another study combined patient brochures with telephone 
reminders.35,36  Limiting ourselves to only “one-way” patient interventions and decision aids 
thus limits the amount of evidence available. However, our interest was the independent effect 
of such interventions on patient knowledge, attitudes, and behavior; this would have been 
difficult to undertake with the studies mentioned. Thirdly, our outcomes of interest were 
limited to just intent, screening uptake, and knowledge. The studies reviewed included other 
potentially important outcomes such as the degree to which patients’ were “informed”, the 
propensity to discuss screening with providers, decisional conflict, and anxiety. These are 
potentially important, and should be included in a future review.  
 The mixed evidence regarding uptake and educational materials suggests a greater need 
for more studies and interventions evaluating patient education and screening behavior. The 
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variation in results may be due in part to the lack of standardization in randomized-controlled 
trial design and educational intervention. For example, this review evaluated   broad patient 
population; a number of studies thus differed in patient characteristics with some evaluating 
only limited literacy patients; others evaluated patients from a number of different 
socioeconomic or otherwise. Another variation was in the methods used to evaluate outcomes; 
there were no standardized tools amongst studies assessing patient intent or education and 
studies evaluated uptake via chart review or patient admission. We suggest that with regards to 
education and intent, standardized questionnaires should be tested and developed in order to 
facilitate outcomes measurement. We further recommend that decision aid content should be 
standardized as well, especially with regards to information, risks and benefits, and exercises. 
Such standardization may facilitate the evaluation of educational materials in the future and 
would thus lead to diminished variability overall.  
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Conclusion 
 Our systematic review suggests that educational materials are effective at improving 
patient knowledge of colorectal cancer and screening, an important consideration especially 
with regards to adequate informed decision-making. The evidence reviewed also suggests a 
mixed effect at improving patient knowledge and intent to become screened. We suggest that 
more evidence and studies are necessary in order to understand the role of patient education 
and screening behavior and attitudes. Nevertheless, if patient knowledge is considered, 
educational materials do have merit in clinical practice, by better enabling patients to 
understand the purposes of screening, lifetime risks of disease, and risks and benefits of 
pursuing screening. Some studies have taken extra steps to provide an option of “no screening” 
in decision aid excercises, in order to better facilitate patient choice and autonomy in informed- 
and shared-decision making. Future studies should incorporate standardized measures for 
patient screening and intent in addition to a means of providing standard content in 
educational materials; this may alleviate the variability of future results.  
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